Effectiveness of HPV Vaccine in Thai Adult Women

CompletedOBSERVATIONAL
Enrollment

993

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Uterine Cervical DysplasiaPapillomavirus Vaccines
Interventions
BIOLOGICAL

Bivalent or Quadrivalent HPV vaccines

Vaccination with at least one dose of Bivalent or Quadrivalent HPV vaccines at least 5 years ago at the ages of 20-45 years

OTHER

Control group

Thai women who did not receive HPV vaccination, either by bivalent or quadrivalent HPV vaccine but have received Pap smear at their ages 20-45 years at least 5 years ago from the current enrollment time

Trial Locations (5)

10110

Bumrungrad International Hospital, Bangkok

10330

King Chulalongkorn Memorial Hospital, Bangkok

10400

National Cancer Institute, Thailand, Bangkok

Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University,, Bangkok

10700

Siriraj Hospital, Mahidol University, Bangkok

Sponsors
All Listed Sponsors
collaborator

National Vaccine Institute, Thailand

OTHER

collaborator

Chulalongkorn University

OTHER

collaborator

National Cancer Institute, Thailand

OTHER_GOV

collaborator

Bumrungrad International Hospital

OTHER

collaborator

Siriraj Hospital

OTHER

lead

Mahidol University

OTHER